Expression of TIA1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

TIA1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 32.49

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

28.1

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	108.4
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	74.4
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	59.4
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	56.9
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	55.9
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	55.1
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	54.5
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	51.2
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	50.9
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	49.4
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	49.3
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	47.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	46.5
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	44.5
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	44.0
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	43.5
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	42.8
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	42.2
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	41.2
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	40.9
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	40.5
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	40.3
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	40.3
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	38.7
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	37.7
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	37.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	36.2
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	34.7
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	34.3
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	33.7
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	33.3
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	33.2
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	32.9
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	32.6
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	32.5
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	32.4
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	32.3
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	31.8
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	31.4
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	30.8
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	30.6
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	30.6
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	30.0
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	29.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	29.8
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	29.7
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	29.7
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	29.3
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	28.8
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	28.7
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	28.5
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	28.3
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	28.3
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	28.2
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	28.1
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	28.1
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	28.0
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	27.9
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	27.8
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	27.6
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	27.6
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	27.5
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	27.3
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	27.3
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	27.1
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	26.8
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	26.6
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	26.6
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	26.5
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	26.2
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	26.0
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	25.9
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	25.5
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	25.2
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	25.2
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	25.2
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	24.9
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	24.5
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	24.4
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	24.4
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	24.0
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	23.8
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	23.8
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	23.5
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	23.3
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	23.1
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	22.8
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	22.7
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	22.6
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	22.6
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	22.1
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	21.9
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	21.9
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	21.9
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	21.8
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	21.6
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	21.3
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	21.1
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	21.1
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	20.9
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	20.9
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	20.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	20.6
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	20.5
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	20.4
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	20.2
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	20.0
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	19.9
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	19.8
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	19.4
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	19.1
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	19.0
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	18.9
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	18.6
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	18.0
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	17.8
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	17.8
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	17.7
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	17.2
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	17.0
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	16.9
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	16.8
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	16.2
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	16.1
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	16.0
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	15.9
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	14.6
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	14.2
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	14.0
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	14.0
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	13.6
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	13.5
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	13.3
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	12.7
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	12.6
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	11.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	11.8
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	11.3
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	11.1
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	10.3
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	8.8
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

TIA1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 24.26

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

21.6

Number of samples

Samples

Sample	Description	TPM
AK102	N, NA, stage:NA, alive, 1740 days	56.3
AK041	N, NA, stage:NA, alive, 810 days	47.4
AK103	N, NA, stage:NA, alive, 1320 days	44.4
AK085	N, NA, stage:NA, alive, 660 days	39.4
AK173	N, NA, stage:NA, dead, 180 days	36.6
AK124	N, NA, stage:NA, alive, 1920 days	36.0
AK156	N, NA, stage:NA, dead, 330 days	35.6
AK066	N, NA, stage:NA, alive, 960 days	34.0
AK199	N, NA, stage:NA, alive, 1860 days	33.2
AK231	N, NA, stage:NA, dead, 240 days	32.9
AK142	N, NA, stage:NA, alive, 90 days	32.4
AK081	N, NA, stage:NA, dead, 180 days	32.0
AK043	N, NA, stage:NA, alive, 660 days	29.9
AK098	N, NA, stage:NA, dead, 660 days	25.6
AK074	N, NA, stage:NA, alive, 300 days	24.4
AK049	N, NA, stage:NA, dead, 180 days	24.2
AK002	N, NA, stage:NA, dead, 570 days	23.6
AK218	N, NA, stage:NA, dead, 180 days	23.2
AK053	N, NA, stage:NA, dead, 300 days	22.8
AK003	N, NA, stage:NA, dead, 600 days	22.7
AK035	N, NA, stage:NA, dead, 210 days	22.5
AK139	N, NA, stage:NA, dead, 270 days	21.9
AK051	N, NA, stage:NA, dead, 360 days	21.7
AK213	N, NA, stage:NA, alive, 2010 days	20.8
AK015	N, NA, stage:NA, alive, 720 days	20.8
AK089	N, NA, stage:NA, dead, 330 days	20.5
AK100	N, NA, stage:NA, alive, 960 days	20.5
AK123	N, NA, stage:NA, dead, 180 days	19.9
AK205	N, NA, stage:NA, dead, 120 days	19.3
AK226	N, NA, stage:NA, dead, 360 days	19.2
AK165	N, NA, stage:NA, alive, 360 days	18.8
AK079	N, NA, stage:NA, dead, 210 days	17.8
AK149	N, NA, stage:NA, dead, 420 days	17.0
AK227	N, NA, stage:NA, alive, 300 days	16.8
AK133	N, NA, stage:NA, dead, 360 days	16.7
AK099	N, NA, stage:NA, dead, 420 days	16.3
AK071	N, NA, stage:NA, dead, 540 days	16.2
AK158	N, NA, stage:NA, dead, 360 days	15.9
AK188	N, NA, stage:NA, alive, 420 days	15.7
AK030	N, NA, stage:NA, dead, 120 days	15.5
AK072	N, NA, stage:NA, dead, 150 days	15.5
AK117	N, NA, stage:NA, dead, 210 days	15.4
AK183	N, NA, stage:NA, alive, 360 days	15.2
AK153	N, NA, stage:NA, dead, 240 days	14.8
AK005	N, NA, stage:NA, dead, 240 days	14.6
AK076	N, NA, stage:NA, alive, 660 days	14.5
AK216	N, NA, stage:NA, dead, 360 days	14.2
AK178	N, NA, stage:NA, dead, 240 days	14.1
AK167	N, NA, stage:NA, dead, 180 days	13.7
AK185	N, NA, stage:NA, alive, 330 days	13.3
AK236	N, NA, stage:NA, dead, 360 days	12.9
AK068	N, NA, stage:NA, alive, 360 days	11.3
AK195	N, NA, stage:NA, dead, 390 days	11.3
AK091	N, NA, stage:NA, dead, 210 days	11.2
AK134	N, NA, stage:NA, dead, 360 days	9.0
AK006	N, NA, stage:NA, dead, 360 days	8.6
AK088	N, NA, stage:NA, dead, 360 days	8.5
AK055	N, NA, stage:NA, dead, 240 days	4.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218770003	Tumor	1.0
CPT0207090003	Tumor	0.8
CPT0161730003	Tumor	0.8
CPT0228220003	Tumor	0.7
CPT0123530003	Tumor	0.7
CPT0217100003	Tumor	0.7
CPT0208980003	Tumor	0.7
CPT0087680003	Tumor	0.6
CPT0224390004	Tumor	0.5
CPT0217190003	Tumor	0.5
CPT0078580003	Tumor	0.4
CPT0206780003	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0189570004	Tumor	0.4
CPT0217710008	Tumor	0.4
CPT0206560003	Tumor	0.4
CPT0064890003	Tumor	0.4
CPT0071100003	Tumor	0.3
CPT0171580008	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0206230003	Tumor	0.3
CPT0224540004	Tumor	0.3
CPT0162140003	Tumor	0.3
CPT0104330003	Tumor	0.2
CPT0087730003	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0218830004	Tumor	0.2
CPT0087570003	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0182550003	Tumor	0.2
CPT0217880003	Tumor	0.2
CPT0218690004	Tumor	0.2
CPT0127480003	Tumor	0.2
CPT0224600003	Tumor	0.2
CPT0218960004	Tumor	0.2
CPT0216920008	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0182580003	Tumor	0.1
CPT0205450004	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0093510003	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0189650004	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0162100003	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0182500003	Tumor	0.1
CPT0092440003	Tumor	0.1
CPT0199770003	Tumor	0.0
CPT0175060003	Tumor	0.0
CPT0168080003	Tumor	0.0
CPT0079790003	Tumor	0.0
CPT0225760003	Tumor	0.0
CPT0218670003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0127420003	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0218330004	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0206000004	Tumor	0.0
CPT0218890004	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0093360003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0093450003	Tumor	-0.1
CPT0190360004	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0217000004	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0206880003	Tumor	-0.2
CPT0168380003	Tumor	-0.2
CPT0204380003	Normal	-0.2
CPT0168270003	Tumor	-0.2
CPT0167970003	Tumor	-0.2
CPT0167640003	Tumor	-0.2
CPT0168590003	Tumor	-0.2
CPT0205890003	Tumor	-0.3
CPT0209440003	Tumor	-0.3
CPT0162020003	Tumor	-0.3
CPT0189750004	Tumor	-0.3
CPT0207030003	Tumor	-0.3
CPT0224330003	Tumor	-0.3
CPT0206110003	Tumor	-0.3
CPT0204340003	Normal	-0.4
CPT0206450003	Tumor	-0.4
CPT0196850003	Tumor	-0.4
CPT0204400003	Normal	-0.4
CPT0204390003	Normal	-0.4
CPT0201710003	Tumor	-0.5
CPT0204360003	Normal	-0.5
CPT0186100003	Tumor	-0.5
CPT0219080004	Tumor	-0.5
CPT0190240004	Tumor	-0.5
CPT0104220003	Tumor	-0.6
CPT0204350003	Normal	-0.6
CPT0204420003	Normal	-0.6
CPT0204330003	Normal	-0.7
CPT0204370003	Normal	-0.7
CPT0204410003	Normal	-0.7
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis